TUMOR-SPECIFIC IMMUNOTHERAPY OF MURINE BLADDER-CANCER WITH BUTANOL-EXTRACTED ANTIGENS AND ETHYLCHLORFORMATE POLYMERIZED TUMOR PROTEIN

被引:1
|
作者
ROCHESTER, MG
SAROSDY, MF
PICKETT, SH
STOGDILL, BJ
LAMM, DL
机构
[1] UNIV TEXAS,HLTH SCI CTR,DIV UROL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284
[2] W VIRGINIA UNIV,DIV UROL,MORGANTOWN,WV 26506
来源
JOURNAL OF UROLOGY | 1988年 / 140卷 / 03期
关键词
D O I
10.1016/S0022-5347(17)41747-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:647 / 650
页数:4
相关论文
共 50 条
  • [31] Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens
    Hiatt, Joseph B.
    Romine, Perrin E.
    Wu, Daniel Y.
    SEMINARS IN ONCOLOGY, 2022, 49 (3-4) : 344 - 352
  • [32] Prostate cancer immunotherapy development using tumor-specific CAR design
    Prima, Victor
    Kusmartsev, Sergei
    Vieweg, Johannes
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [33] Specific immunotherapy of bladder cancer: the peculiarities of cultivation of tumor cells
    Avdonkina, N.
    Slavyanskaya, T.
    Baldueva, I
    Salnikova, S.
    ALLERGY, 2016, 71 : 630 - 630
  • [34] Intravesical bacterial immunotherapy for bladder cancer can elicit tumor-specific immunity and relies on the capacity of the bacteria to infect and persist in the bladder
    Moreo, Eduardo
    Uranga, Santiago
    Martin, Carlos
    Aguilo, Nacho
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 122 - 122
  • [35] TUMOR RELAPSE PROPHYLAXIS WITH BCG IN SUPERFICIAL BLADDER-CANCER - A MODEL FOR EFFECTIVE IMMUNOTHERAPY OF NEOPLASMS
    SCHILLING, A
    LAMM, DL
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (36): : 538 - 541
  • [36] INCREASED EXPRESSION OF GENES ENCODING TUMOR-SPECIFIC ANTIGENS IN OCULAR MELANOMA - POTENTIAL TARGETS FOR IMMUNOTHERAPY
    CHEN, PW
    SALGALLER, ML
    ROSENBERG, SA
    MURRAY, T
    KSANDER, BR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S221 - S221
  • [38] BCG IMMUNOTHERAPY OF BLADDER-CANCER - INHIBITION OF TUMOR RECURRENCE AND ASSOCIATED IMMUNE-RESPONSES
    LAMM, DL
    THOR, DE
    WINTERS, WD
    STOGDILL, VD
    RADWIN, HM
    CANCER, 1981, 48 (01) : 82 - 88
  • [39] Proteogenomics uncovers a vast repertoire of shared tumor-specific antigens in ovarian cancer
    Zhao, Q.
    Laverdure, J. -P.
    Lanoix, J.
    Durette, C.
    Cote, C.
    Bonneil, E.
    Laumont, C.
    Gendron, P.
    Vincent, K.
    Lemieux, S.
    Millar, D.
    Ohashi, P.
    Thibault, P.
    Perreault, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1514 - 1515
  • [40] ACTIVE, TUMOR-SPECIFIC IMMUNOTHERAPY OF LSTRA MURINE LEUKEMIA USING IRRADIATED TUMOR-CELLS AND CORYNEBACTERIUM-PARVUM
    BARTLETT, GL
    KREIDER, JW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 189 - 189